Hashimoto's thyroiditis medical therapy

Jump to navigation Jump to search

Hashimoto's thyroiditis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hashimoto's Thyroiditis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary prevention

Secondary prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hashimoto's thyroiditis medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hashimoto's thyroiditis medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hashimoto's thyroiditis medical therapy

CDC on Hashimoto's thyroiditis medical therapy

Hashimoto's thyroiditis medical therapy in the news

Blogs on Hashimoto's thyroiditis medical therapy

Directions to Hospitals Treating Hashimoto's thyroiditis

Risk calculators and risk factors for Hashimoto's thyroiditis medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Furqan M M. M.B.B.S[2]

Overview

Medical Therapy

The drugs used in the treatment of Hashimoto's thyroiditis are:

  • Levothyroxine:
    • lifelong synthetic levothyroxine (L-T4) is used to treat the hypothyroidism in Hashimoto's disease.
  • Corticosteroids:
    • A short course of glucocorticoids can be used in the treatment of IgG4-related variant of Hashimoto's thyroiditis.
  • Selenium:
    • Dietary selenium supplementation is considered to be protective against the autoimmune diseases of the thyroid.

Drug Regimen:

  • Synthetic levothyroxine (L-T4) 1.6–1.8 μg/kg of body weight per day orally.

References

Template:WH Template:WS